CoChat

PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results?

Mannarino, Massimo R., Sahebkar, Amirhossein, Bianconi, Vanessa, Serban, Maria-Corina, Banach, Maciej, Pirro, Matteo · 2018 · Journal of Clinical Lipidology
Cited by 48

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

The serine protease proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates the levels of low-density lipoprotein cholesterol and cardiovascular risk. Potential risks of adverse neurological effects of intensive lipid-lowering treatment have been hypothesized, as cholesterol is a component of the central nervous system. Moreover, several observations suggest that PCSK9 might play a role in neurogenesis, neuronal migration and apoptosis. In rodents, increased expression of PCSK9 has been detected in specific areas of the central nervous system during embryonic development; also, PCSK9 modulates low-density lipoprotein receptor levels in the ischemic brain areas. Despite a putative participation of PCSK9 in nervous system physiology, the absence of PCSK9 in knockout mice or in humans with loss-of-function mutations of PCSK9 gene has not been linked to neurological alterations. In recent years, some concerns have been raised about the potential neurological side effects of cholesterol-lowering treatments and, more specifically of PCSK9 inhibitors. In this review, the evidence regarding the function of PCSK9 in neuron differentiation, apoptosis, and migration and in nervous system development and latest clinical trials evaluating the effects of PCSK9 inhibitors on neurocognitive function will be described.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacl.2018.05.012

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 48

Metadata

Authors
Mannarino, M. R., Sahebkar, A., Bianconi, V., Serban, M.-C., Banach, M., & Pirro, M.
Venue
Journal of Clinical Lipidology
Publisher
Elsevier BV
Published
2018-09
Volume
12
Issue
5
Pages
1123-1132
ISSN
  • 1876-4789 (ISSN-L)
  • 1933-2874
OpenAlex
W2807085521
Cited by
48
References
32
FWCI
7.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results? https://app.cochat.ai/papers/10.1016/j.jacl.2018.05.012
The paper
Mannarino, M. R., Sahebkar, A., Bianconi, V., Serban, M.-C., Banach, M., & Pirro, M. (2018). PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results? Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2018.05.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.